Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05121103
Title A Study in Subjects With Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Epizyme, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
Astera Cancer Care East Brunswick New Jersey 08816 United States Details
Weill Cornell Medicine New York New York 10021 United States Details
Icahn School of Medicine at Mount Sinai New York New York 10029 United States Details
Memorial Sloan-Kettering Cancer Center New York New York 10065 United States Details
Baylor University Medical Center (Texas Oncology) Dallas Texas 75246 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
NEXT Virginia Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field